Glucophage XR Generics Will Be Early Test Of Bristol/FTC Settlement
Executive Summary
The expiration of marketing exclusivity forGlucophage XR will provide an early test of the impact of Bristol-Myers Squibb's settlement with the Federal Trade Commission over Bristol's aggressive patent defense tactics